# An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%

> **NCT00668655** · — · COMPLETED · sponsor: **Galderma R&D** · enrollment: 30 (actual)

## Conditions studied

- Rosacea

## Interventions

- **DRUG:** Metronidazole Gel

## Key facts

- **NCT ID:** NCT00668655
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668655, "An Evaluation of the Cosmetic Appearance of Metronidazole Gel (MetroGel®) 1%". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00668655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
